Fresh Tracks Therapeuticsinc Formerly Known As Brickell Biotechinc Is A Biopharmaceutical Company Based In Bouldercoloradofounded In 2009The Company Focused On Developing Prescription Therapeutics For Autoimmune And Inflammatory Diseasestheir Product Pipeline Included Bbi 02An Oral Dyrk1A Inhibitor For Conditions Like Atopic Dermatitis And Rheumatoid Arthritisbbi 03A Topical Dyrk1A Inhibitor For Dermatological Autoimmune Diseasesand Bbi 10An Orally Available Covalent Sting Inhibitor For Inflammatory Diseases Fresh Tracks Therapeutics Utilized A Proprietary Kinase Inhibitor Platform And Collaborated With Various Pharmaceutical And Biotechnology Companiesgovernment Agenciesand Research Institutions To Advance Their Therapeutic Productsas Of October 2023The Company Has Discontinued All Development Programs And Is In The Process Of Liquidation And Dissolution
